ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Tenofovir Disoproxil Fumarate Drug Substance Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-38C13560
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Tenofovir Disoproxil Fumarate Drug Substance Market Research Report 2023
BUY CHAPTERS

Global Tenofovir Disoproxil Fumarate Drug Substance Market Research Report 2025

Code: QYRE-Auto-38C13560
Report
March 2025
Pages:109
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Macleods Pharmaceuticals Ltd
Hetero Labs Ltd
Aurobindo Pharma Ltd.
MYLAN LABORATORIES LTD
Cipla Ltd
Emcure Pharmaceuticals Ltd.
LAURUS LABS LTD
Aurisco Pharmaceutical Co.,Ltd
SOLARA ACTIVE PHARMA SCIENCES LTD
Lupin Ltd
Zhejiang Huahai Pharmaceutical Co., Ltd.
VIYASH LIFE SCIENCES PRIVATE LTD
STYRAX PHARMA PRIVATE LTD
ACEBRIGHT INDIA PHARMA PRIVATE LTD
SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD
ZHEJIANG CANDORLY PHARMACEUTICAL CO LTD
ZHEJIANG SUPOR PHARMACEUTICALS CO LTD
SHANDONG ANHONG PHARMACEUTICAL CO LTD
JINGMEN SHUAIBANG CHEMICAL SCIENCE AND TECHNOLOGY CO LTD

Tenofovir Disoproxil Fumarate Drug Substance Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Tenofovir Disoproxil Fumarate Drug Substance Market

Tenofovir Disoproxil Fumarate Drug Substance Market

The global market for Tenofovir Disoproxil Fumarate Drug Substance was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Tenofovir Disoproxil Fumarate Drug Substance, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tenofovir Disoproxil Fumarate Drug Substance.
The Tenofovir Disoproxil Fumarate Drug Substance market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Tenofovir Disoproxil Fumarate Drug Substance market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tenofovir Disoproxil Fumarate Drug Substance manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Tenofovir Disoproxil Fumarate Drug Substance Market Report

Report Metric Details
Report Name Tenofovir Disoproxil Fumarate Drug Substance Market
CAGR 5%
by Type
  • Purity≥99%
  • Purity<99%
by Application
  • Tablet
  • Granule
  • Capsule
  • Oral Powder
Production by Region
  • North America
  • Europe
  • China
  • Japan
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company MACLEODS PHARMACEUTICALS LTD, HETERO LABS LTD, AUROBINDO PHARMA LTD, MYLAN LABORATORIES LTD, CIPLA LTD, VIYASH LIFE SCIENCES PRIVATE LTD, EMCURE PHARMACEUTICALS LTD, STYRAX PHARMA PRIVATE LTD, LAURUS LABS LTD, AURISCO PHARMACEUTICAL CO LTD, ACEBRIGHT INDIA PHARMA PRIVATE LTD, SOLARA ACTIVE PHARMA SCIENCES LTD, LUPIN LTD, SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD, ZHEJIANG CANDORLY PHARMACEUTICAL CO LTD, ZHEJIANG SUPOR PHARMACEUTICALS CO LTD, SHANDONG ANHONG PHARMACEUTICAL CO LTD, JINGMEN SHUAIBANG CHEMICAL SCIENCE AND TECHNOLOGY CO LTD, ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Tenofovir Disoproxil Fumarate Drug Substance manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Production/output, value of Tenofovir Disoproxil Fumarate Drug Substance by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
  • Chapter 4: Consumption of Tenofovir Disoproxil Fumarate Drug Substance in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 10: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Tenofovir Disoproxil Fumarate Drug Substance Market report?

Ans: The main players in the Tenofovir Disoproxil Fumarate Drug Substance Market are MACLEODS PHARMACEUTICALS LTD, HETERO LABS LTD, AUROBINDO PHARMA LTD, MYLAN LABORATORIES LTD, CIPLA LTD, VIYASH LIFE SCIENCES PRIVATE LTD, EMCURE PHARMACEUTICALS LTD, STYRAX PHARMA PRIVATE LTD, LAURUS LABS LTD, AURISCO PHARMACEUTICAL CO LTD, ACEBRIGHT INDIA PHARMA PRIVATE LTD, SOLARA ACTIVE PHARMA SCIENCES LTD, LUPIN LTD, SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD, ZHEJIANG CANDORLY PHARMACEUTICAL CO LTD, ZHEJIANG SUPOR PHARMACEUTICALS CO LTD, SHANDONG ANHONG PHARMACEUTICAL CO LTD, JINGMEN SHUAIBANG CHEMICAL SCIENCE AND TECHNOLOGY CO LTD, ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD

What are the Application segmentation covered in the Tenofovir Disoproxil Fumarate Drug Substance Market report?

Ans: The Applications covered in the Tenofovir Disoproxil Fumarate Drug Substance Market report are Tablet, Granule, Capsule, Oral Powder

What are the Type segmentation covered in the Tenofovir Disoproxil Fumarate Drug Substance Market report?

Ans: The Types covered in the Tenofovir Disoproxil Fumarate Drug Substance Market report are Purity≥99%, Purity<99%

Recommended Reports

Antiviral & HIV Drugs

API & Fumarate Market

Broad Pharmaceutical APIs

1 Tenofovir Disoproxil Fumarate Drug Substance Market Overview
1.1 Product Definition
1.2 Tenofovir Disoproxil Fumarate Drug Substance by Type
1.2.1 Global Tenofovir Disoproxil Fumarate Drug Substance Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 Purity≥99%
1.2.3 Purity<99%
1.3 Tenofovir Disoproxil Fumarate Drug Substance by Application
1.3.1 Global Tenofovir Disoproxil Fumarate Drug Substance Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Tablet
1.3.3 Granule
1.3.4 Capsule
1.3.5 Oral Powder
1.4 Global Market Growth Prospects
1.4.1 Global Tenofovir Disoproxil Fumarate Drug Substance Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Tenofovir Disoproxil Fumarate Drug Substance Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Tenofovir Disoproxil Fumarate Drug Substance Production Estimates and Forecasts (2020-2031)
1.4.4 Global Tenofovir Disoproxil Fumarate Drug Substance Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Tenofovir Disoproxil Fumarate Drug Substance Production Market Share by Manufacturers (2020-2025)
2.2 Global Tenofovir Disoproxil Fumarate Drug Substance Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Tenofovir Disoproxil Fumarate Drug Substance, Industry Ranking, 2023 VS 2024
2.4 Global Tenofovir Disoproxil Fumarate Drug Substance Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Tenofovir Disoproxil Fumarate Drug Substance Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Tenofovir Disoproxil Fumarate Drug Substance, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Tenofovir Disoproxil Fumarate Drug Substance, Product Offered and Application
2.8 Global Key Manufacturers of Tenofovir Disoproxil Fumarate Drug Substance, Date of Enter into This Industry
2.9 Tenofovir Disoproxil Fumarate Drug Substance Market Competitive Situation and Trends
2.9.1 Tenofovir Disoproxil Fumarate Drug Substance Market Concentration Rate
2.9.2 Global 5 and 10 Largest Tenofovir Disoproxil Fumarate Drug Substance Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Tenofovir Disoproxil Fumarate Drug Substance Production by Region
3.1 Global Tenofovir Disoproxil Fumarate Drug Substance Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Tenofovir Disoproxil Fumarate Drug Substance Production Value by Region (2020-2031)
3.2.1 Global Tenofovir Disoproxil Fumarate Drug Substance Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Tenofovir Disoproxil Fumarate Drug Substance by Region (2026-2031)
3.3 Global Tenofovir Disoproxil Fumarate Drug Substance Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Tenofovir Disoproxil Fumarate Drug Substance Production Volume by Region (2020-2031)
3.4.1 Global Tenofovir Disoproxil Fumarate Drug Substance Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Tenofovir Disoproxil Fumarate Drug Substance by Region (2026-2031)
3.5 Global Tenofovir Disoproxil Fumarate Drug Substance Market Price Analysis by Region (2020-2025)
3.6 Global Tenofovir Disoproxil Fumarate Drug Substance Production and Value, Year-over-Year Growth
3.6.1 North America Tenofovir Disoproxil Fumarate Drug Substance Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Tenofovir Disoproxil Fumarate Drug Substance Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Tenofovir Disoproxil Fumarate Drug Substance Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Tenofovir Disoproxil Fumarate Drug Substance Production Value Estimates and Forecasts (2020-2031)
4 Tenofovir Disoproxil Fumarate Drug Substance Consumption by Region
4.1 Global Tenofovir Disoproxil Fumarate Drug Substance Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Tenofovir Disoproxil Fumarate Drug Substance Consumption by Region (2020-2031)
4.2.1 Global Tenofovir Disoproxil Fumarate Drug Substance Consumption by Region (2020-2025)
4.2.2 Global Tenofovir Disoproxil Fumarate Drug Substance Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Tenofovir Disoproxil Fumarate Drug Substance Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Tenofovir Disoproxil Fumarate Drug Substance Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Tenofovir Disoproxil Fumarate Drug Substance Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Tenofovir Disoproxil Fumarate Drug Substance Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Tenofovir Disoproxil Fumarate Drug Substance Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Tenofovir Disoproxil Fumarate Drug Substance Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Tenofovir Disoproxil Fumarate Drug Substance Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Tenofovir Disoproxil Fumarate Drug Substance Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Tenofovir Disoproxil Fumarate Drug Substance Production by Type (2020-2031)
5.1.1 Global Tenofovir Disoproxil Fumarate Drug Substance Production by Type (2020-2025)
5.1.2 Global Tenofovir Disoproxil Fumarate Drug Substance Production by Type (2026-2031)
5.1.3 Global Tenofovir Disoproxil Fumarate Drug Substance Production Market Share by Type (2020-2031)
5.2 Global Tenofovir Disoproxil Fumarate Drug Substance Production Value by Type (2020-2031)
5.2.1 Global Tenofovir Disoproxil Fumarate Drug Substance Production Value by Type (2020-2025)
5.2.2 Global Tenofovir Disoproxil Fumarate Drug Substance Production Value by Type (2026-2031)
5.2.3 Global Tenofovir Disoproxil Fumarate Drug Substance Production Value Market Share by Type (2020-2031)
5.3 Global Tenofovir Disoproxil Fumarate Drug Substance Price by Type (2020-2031)
6 Segment by Application
6.1 Global Tenofovir Disoproxil Fumarate Drug Substance Production by Application (2020-2031)
6.1.1 Global Tenofovir Disoproxil Fumarate Drug Substance Production by Application (2020-2025)
6.1.2 Global Tenofovir Disoproxil Fumarate Drug Substance Production by Application (2026-2031)
6.1.3 Global Tenofovir Disoproxil Fumarate Drug Substance Production Market Share by Application (2020-2031)
6.2 Global Tenofovir Disoproxil Fumarate Drug Substance Production Value by Application (2020-2031)
6.2.1 Global Tenofovir Disoproxil Fumarate Drug Substance Production Value by Application (2020-2025)
6.2.2 Global Tenofovir Disoproxil Fumarate Drug Substance Production Value by Application (2026-2031)
6.2.3 Global Tenofovir Disoproxil Fumarate Drug Substance Production Value Market Share by Application (2020-2031)
6.3 Global Tenofovir Disoproxil Fumarate Drug Substance Price by Application (2020-2031)
7 Key Companies Profiled
7.1 MACLEODS PHARMACEUTICALS LTD
7.1.1 MACLEODS PHARMACEUTICALS LTD Tenofovir Disoproxil Fumarate Drug Substance Company Information
7.1.2 MACLEODS PHARMACEUTICALS LTD Tenofovir Disoproxil Fumarate Drug Substance Product Portfolio
7.1.3 MACLEODS PHARMACEUTICALS LTD Tenofovir Disoproxil Fumarate Drug Substance Production, Value, Price and Gross Margin (2020-2025)
7.1.4 MACLEODS PHARMACEUTICALS LTD Main Business and Markets Served
7.1.5 MACLEODS PHARMACEUTICALS LTD Recent Developments/Updates
7.2 HETERO LABS LTD
7.2.1 HETERO LABS LTD Tenofovir Disoproxil Fumarate Drug Substance Company Information
7.2.2 HETERO LABS LTD Tenofovir Disoproxil Fumarate Drug Substance Product Portfolio
7.2.3 HETERO LABS LTD Tenofovir Disoproxil Fumarate Drug Substance Production, Value, Price and Gross Margin (2020-2025)
7.2.4 HETERO LABS LTD Main Business and Markets Served
7.2.5 HETERO LABS LTD Recent Developments/Updates
7.3 AUROBINDO PHARMA LTD
7.3.1 AUROBINDO PHARMA LTD Tenofovir Disoproxil Fumarate Drug Substance Company Information
7.3.2 AUROBINDO PHARMA LTD Tenofovir Disoproxil Fumarate Drug Substance Product Portfolio
7.3.3 AUROBINDO PHARMA LTD Tenofovir Disoproxil Fumarate Drug Substance Production, Value, Price and Gross Margin (2020-2025)
7.3.4 AUROBINDO PHARMA LTD Main Business and Markets Served
7.3.5 AUROBINDO PHARMA LTD Recent Developments/Updates
7.4 MYLAN LABORATORIES LTD
7.4.1 MYLAN LABORATORIES LTD Tenofovir Disoproxil Fumarate Drug Substance Company Information
7.4.2 MYLAN LABORATORIES LTD Tenofovir Disoproxil Fumarate Drug Substance Product Portfolio
7.4.3 MYLAN LABORATORIES LTD Tenofovir Disoproxil Fumarate Drug Substance Production, Value, Price and Gross Margin (2020-2025)
7.4.4 MYLAN LABORATORIES LTD Main Business and Markets Served
7.4.5 MYLAN LABORATORIES LTD Recent Developments/Updates
7.5 CIPLA LTD
7.5.1 CIPLA LTD Tenofovir Disoproxil Fumarate Drug Substance Company Information
7.5.2 CIPLA LTD Tenofovir Disoproxil Fumarate Drug Substance Product Portfolio
7.5.3 CIPLA LTD Tenofovir Disoproxil Fumarate Drug Substance Production, Value, Price and Gross Margin (2020-2025)
7.5.4 CIPLA LTD Main Business and Markets Served
7.5.5 CIPLA LTD Recent Developments/Updates
7.6 VIYASH LIFE SCIENCES PRIVATE LTD
7.6.1 VIYASH LIFE SCIENCES PRIVATE LTD Tenofovir Disoproxil Fumarate Drug Substance Company Information
7.6.2 VIYASH LIFE SCIENCES PRIVATE LTD Tenofovir Disoproxil Fumarate Drug Substance Product Portfolio
7.6.3 VIYASH LIFE SCIENCES PRIVATE LTD Tenofovir Disoproxil Fumarate Drug Substance Production, Value, Price and Gross Margin (2020-2025)
7.6.4 VIYASH LIFE SCIENCES PRIVATE LTD Main Business and Markets Served
7.6.5 VIYASH LIFE SCIENCES PRIVATE LTD Recent Developments/Updates
7.7 EMCURE PHARMACEUTICALS LTD
7.7.1 EMCURE PHARMACEUTICALS LTD Tenofovir Disoproxil Fumarate Drug Substance Company Information
7.7.2 EMCURE PHARMACEUTICALS LTD Tenofovir Disoproxil Fumarate Drug Substance Product Portfolio
7.7.3 EMCURE PHARMACEUTICALS LTD Tenofovir Disoproxil Fumarate Drug Substance Production, Value, Price and Gross Margin (2020-2025)
7.7.4 EMCURE PHARMACEUTICALS LTD Main Business and Markets Served
7.7.5 EMCURE PHARMACEUTICALS LTD Recent Developments/Updates
7.8 STYRAX PHARMA PRIVATE LTD
7.8.1 STYRAX PHARMA PRIVATE LTD Tenofovir Disoproxil Fumarate Drug Substance Company Information
7.8.2 STYRAX PHARMA PRIVATE LTD Tenofovir Disoproxil Fumarate Drug Substance Product Portfolio
7.8.3 STYRAX PHARMA PRIVATE LTD Tenofovir Disoproxil Fumarate Drug Substance Production, Value, Price and Gross Margin (2020-2025)
7.8.4 STYRAX PHARMA PRIVATE LTD Main Business and Markets Served
7.8.5 STYRAX PHARMA PRIVATE LTD Recent Developments/Updates
7.9 LAURUS LABS LTD
7.9.1 LAURUS LABS LTD Tenofovir Disoproxil Fumarate Drug Substance Company Information
7.9.2 LAURUS LABS LTD Tenofovir Disoproxil Fumarate Drug Substance Product Portfolio
7.9.3 LAURUS LABS LTD Tenofovir Disoproxil Fumarate Drug Substance Production, Value, Price and Gross Margin (2020-2025)
7.9.4 LAURUS LABS LTD Main Business and Markets Served
7.9.5 LAURUS LABS LTD Recent Developments/Updates
7.10 AURISCO PHARMACEUTICAL CO LTD
7.10.1 AURISCO PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Company Information
7.10.2 AURISCO PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Product Portfolio
7.10.3 AURISCO PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Production, Value, Price and Gross Margin (2020-2025)
7.10.4 AURISCO PHARMACEUTICAL CO LTD Main Business and Markets Served
7.10.5 AURISCO PHARMACEUTICAL CO LTD Recent Developments/Updates
7.11 ACEBRIGHT INDIA PHARMA PRIVATE LTD
7.11.1 ACEBRIGHT INDIA PHARMA PRIVATE LTD Tenofovir Disoproxil Fumarate Drug Substance Company Information
7.11.2 ACEBRIGHT INDIA PHARMA PRIVATE LTD Tenofovir Disoproxil Fumarate Drug Substance Product Portfolio
7.11.3 ACEBRIGHT INDIA PHARMA PRIVATE LTD Tenofovir Disoproxil Fumarate Drug Substance Production, Value, Price and Gross Margin (2020-2025)
7.11.4 ACEBRIGHT INDIA PHARMA PRIVATE LTD Main Business and Markets Served
7.11.5 ACEBRIGHT INDIA PHARMA PRIVATE LTD Recent Developments/Updates
7.12 SOLARA ACTIVE PHARMA SCIENCES LTD
7.12.1 SOLARA ACTIVE PHARMA SCIENCES LTD Tenofovir Disoproxil Fumarate Drug Substance Company Information
7.12.2 SOLARA ACTIVE PHARMA SCIENCES LTD Tenofovir Disoproxil Fumarate Drug Substance Product Portfolio
7.12.3 SOLARA ACTIVE PHARMA SCIENCES LTD Tenofovir Disoproxil Fumarate Drug Substance Production, Value, Price and Gross Margin (2020-2025)
7.12.4 SOLARA ACTIVE PHARMA SCIENCES LTD Main Business and Markets Served
7.12.5 SOLARA ACTIVE PHARMA SCIENCES LTD Recent Developments/Updates
7.13 LUPIN LTD
7.13.1 LUPIN LTD Tenofovir Disoproxil Fumarate Drug Substance Company Information
7.13.2 LUPIN LTD Tenofovir Disoproxil Fumarate Drug Substance Product Portfolio
7.13.3 LUPIN LTD Tenofovir Disoproxil Fumarate Drug Substance Production, Value, Price and Gross Margin (2020-2025)
7.13.4 LUPIN LTD Main Business and Markets Served
7.13.5 LUPIN LTD Recent Developments/Updates
7.14 SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD
7.14.1 SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Company Information
7.14.2 SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Product Portfolio
7.14.3 SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Production, Value, Price and Gross Margin (2020-2025)
7.14.4 SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD Main Business and Markets Served
7.14.5 SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD Recent Developments/Updates
7.15 ZHEJIANG CANDORLY PHARMACEUTICAL CO LTD
7.15.1 ZHEJIANG CANDORLY PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Company Information
7.15.2 ZHEJIANG CANDORLY PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Product Portfolio
7.15.3 ZHEJIANG CANDORLY PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Production, Value, Price and Gross Margin (2020-2025)
7.15.4 ZHEJIANG CANDORLY PHARMACEUTICAL CO LTD Main Business and Markets Served
7.15.5 ZHEJIANG CANDORLY PHARMACEUTICAL CO LTD Recent Developments/Updates
7.16 ZHEJIANG SUPOR PHARMACEUTICALS CO LTD
7.16.1 ZHEJIANG SUPOR PHARMACEUTICALS CO LTD Tenofovir Disoproxil Fumarate Drug Substance Company Information
7.16.2 ZHEJIANG SUPOR PHARMACEUTICALS CO LTD Tenofovir Disoproxil Fumarate Drug Substance Product Portfolio
7.16.3 ZHEJIANG SUPOR PHARMACEUTICALS CO LTD Tenofovir Disoproxil Fumarate Drug Substance Production, Value, Price and Gross Margin (2020-2025)
7.16.4 ZHEJIANG SUPOR PHARMACEUTICALS CO LTD Main Business and Markets Served
7.16.5 ZHEJIANG SUPOR PHARMACEUTICALS CO LTD Recent Developments/Updates
7.17 SHANDONG ANHONG PHARMACEUTICAL CO LTD
7.17.1 SHANDONG ANHONG PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Company Information
7.17.2 SHANDONG ANHONG PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Product Portfolio
7.17.3 SHANDONG ANHONG PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Production, Value, Price and Gross Margin (2020-2025)
7.17.4 SHANDONG ANHONG PHARMACEUTICAL CO LTD Main Business and Markets Served
7.17.5 SHANDONG ANHONG PHARMACEUTICAL CO LTD Recent Developments/Updates
7.18 JINGMEN SHUAIBANG CHEMICAL SCIENCE AND TECHNOLOGY CO LTD
7.18.1 JINGMEN SHUAIBANG CHEMICAL SCIENCE AND TECHNOLOGY CO LTD Tenofovir Disoproxil Fumarate Drug Substance Company Information
7.18.2 JINGMEN SHUAIBANG CHEMICAL SCIENCE AND TECHNOLOGY CO LTD Tenofovir Disoproxil Fumarate Drug Substance Product Portfolio
7.18.3 JINGMEN SHUAIBANG CHEMICAL SCIENCE AND TECHNOLOGY CO LTD Tenofovir Disoproxil Fumarate Drug Substance Production, Value, Price and Gross Margin (2020-2025)
7.18.4 JINGMEN SHUAIBANG CHEMICAL SCIENCE AND TECHNOLOGY CO LTD Main Business and Markets Served
7.18.5 JINGMEN SHUAIBANG CHEMICAL SCIENCE AND TECHNOLOGY CO LTD Recent Developments/Updates
7.19 ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD
7.19.1 ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Company Information
7.19.2 ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Product Portfolio
7.19.3 ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Production, Value, Price and Gross Margin (2020-2025)
7.19.4 ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD Main Business and Markets Served
7.19.5 ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Tenofovir Disoproxil Fumarate Drug Substance Industry Chain Analysis
8.2 Tenofovir Disoproxil Fumarate Drug Substance Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Tenofovir Disoproxil Fumarate Drug Substance Production Mode & Process Analysis
8.4 Tenofovir Disoproxil Fumarate Drug Substance Sales and Marketing
8.4.1 Tenofovir Disoproxil Fumarate Drug Substance Sales Channels
8.4.2 Tenofovir Disoproxil Fumarate Drug Substance Distributors
8.5 Tenofovir Disoproxil Fumarate Drug Substance Customer Analysis
9 Tenofovir Disoproxil Fumarate Drug Substance Market Dynamics
9.1 Tenofovir Disoproxil Fumarate Drug Substance Industry Trends
9.2 Tenofovir Disoproxil Fumarate Drug Substance Market Drivers
9.3 Tenofovir Disoproxil Fumarate Drug Substance Market Challenges
9.4 Tenofovir Disoproxil Fumarate Drug Substance Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
FEATURED COMPANIES
Macleods Pharmaceuticals Ltd
Hetero Labs Ltd
Aurobindo Pharma Ltd.
MYLAN LABORATORIES LTD
Cipla Ltd
Emcure Pharmaceuticals Ltd.
LAURUS LABS LTD
Aurisco Pharmaceutical Co.,Ltd
SOLARA ACTIVE PHARMA SCIENCES LTD
Lupin Ltd
Zhejiang Huahai Pharmaceutical Co., Ltd.
VIYASH LIFE SCIENCES PRIVATE LTD
STYRAX PHARMA PRIVATE LTD
ACEBRIGHT INDIA PHARMA PRIVATE LTD
SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD
ZHEJIANG CANDORLY PHARMACEUTICAL CO LTD
ZHEJIANG SUPOR PHARMACEUTICALS CO LTD
SHANDONG ANHONG PHARMACEUTICAL CO LTD
JINGMEN SHUAIBANG CHEMICAL SCIENCE AND TECHNOLOGY CO LTD
List of Tables
 Table 1. Global Tenofovir Disoproxil Fumarate Drug Substance Market Value by Type, (US$ Million) & (2024 VS 2031)
 Table 2. Global Tenofovir Disoproxil Fumarate Drug Substance Market Value by Application, (US$ Million) & (2024 VS 2031)
 Table 3. Global Tenofovir Disoproxil Fumarate Drug Substance Production Capacity (Tons) by Manufacturers in 2024
 Table 4. Global Tenofovir Disoproxil Fumarate Drug Substance Production by Manufacturers (2020-2025) & (Tons)
 Table 5. Global Tenofovir Disoproxil Fumarate Drug Substance Production Market Share by Manufacturers (2020-2025)
 Table 6. Global Tenofovir Disoproxil Fumarate Drug Substance Production Value by Manufacturers (2020-2025) & (US$ Million)
 Table 7. Global Tenofovir Disoproxil Fumarate Drug Substance Production Value Share by Manufacturers (2020-2025)
 Table 8. Global Key Players of Tenofovir Disoproxil Fumarate Drug Substance, Industry Ranking, 2023 VS 2024
 Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Tenofovir Disoproxil Fumarate Drug Substance as of 2024)
 Table 10. Global Market Tenofovir Disoproxil Fumarate Drug Substance Average Price by Manufacturers (US$/Ton) & (2020-2025)
 Table 11. Global Key Manufacturers of Tenofovir Disoproxil Fumarate Drug Substance, Manufacturing Base Distribution and Headquarters
 Table 12. Global Key Manufacturers of Tenofovir Disoproxil Fumarate Drug Substance, Product Offered and Application
 Table 13. Global Key Manufacturers of Tenofovir Disoproxil Fumarate Drug Substance, Date of Enter into This Industry
 Table 14. Global Tenofovir Disoproxil Fumarate Drug Substance Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 15. Mergers & Acquisitions, Expansion Plans
 Table 16. Global Tenofovir Disoproxil Fumarate Drug Substance Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 17. Global Tenofovir Disoproxil Fumarate Drug Substance Production Value (US$ Million) by Region (2020-2025)
 Table 18. Global Tenofovir Disoproxil Fumarate Drug Substance Production Value Market Share by Region (2020-2025)
 Table 19. Global Tenofovir Disoproxil Fumarate Drug Substance Production Value (US$ Million) Forecast by Region (2026-2031)
 Table 20. Global Tenofovir Disoproxil Fumarate Drug Substance Production Value Market Share Forecast by Region (2026-2031)
 Table 21. Global Tenofovir Disoproxil Fumarate Drug Substance Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 22. Global Tenofovir Disoproxil Fumarate Drug Substance Production (Tons) by Region (2020-2025)
 Table 23. Global Tenofovir Disoproxil Fumarate Drug Substance Production Market Share by Region (2020-2025)
 Table 24. Global Tenofovir Disoproxil Fumarate Drug Substance Production (Tons) Forecast by Region (2026-2031)
 Table 25. Global Tenofovir Disoproxil Fumarate Drug Substance Production Market Share Forecast by Region (2026-2031)
 Table 26. Global Tenofovir Disoproxil Fumarate Drug Substance Market Average Price (US$/Ton) by Region (2020-2025)
 Table 27. Global Tenofovir Disoproxil Fumarate Drug Substance Market Average Price (US$/Ton) by Region (2026-2031)
 Table 28. Global Tenofovir Disoproxil Fumarate Drug Substance Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 29. Global Tenofovir Disoproxil Fumarate Drug Substance Consumption by Region (2020-2025) & (Tons)
 Table 30. Global Tenofovir Disoproxil Fumarate Drug Substance Consumption Market Share by Region (2020-2025)
 Table 31. Global Tenofovir Disoproxil Fumarate Drug Substance Forecasted Consumption by Region (2026-2031) & (Tons)
 Table 32. Global Tenofovir Disoproxil Fumarate Drug Substance Forecasted Consumption Market Share by Region (2026-2031)
 Table 33. North America Tenofovir Disoproxil Fumarate Drug Substance Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
 Table 34. North America Tenofovir Disoproxil Fumarate Drug Substance Consumption by Country (2020-2025) & (Tons)
 Table 35. North America Tenofovir Disoproxil Fumarate Drug Substance Consumption by Country (2026-2031) & (Tons)
 Table 36. Europe Tenofovir Disoproxil Fumarate Drug Substance Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
 Table 37. Europe Tenofovir Disoproxil Fumarate Drug Substance Consumption by Country (2020-2025) & (Tons)
 Table 38. Europe Tenofovir Disoproxil Fumarate Drug Substance Consumption by Country (2026-2031) & (Tons)
 Table 39. Asia Pacific Tenofovir Disoproxil Fumarate Drug Substance Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 40. Asia Pacific Tenofovir Disoproxil Fumarate Drug Substance Consumption by Region (2020-2025) & (Tons)
 Table 41. Asia Pacific Tenofovir Disoproxil Fumarate Drug Substance Consumption by Region (2026-2031) & (Tons)
 Table 42. Latin America, Middle East & Africa Tenofovir Disoproxil Fumarate Drug Substance Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
 Table 43. Latin America, Middle East & Africa Tenofovir Disoproxil Fumarate Drug Substance Consumption by Country (2020-2025) & (Tons)
 Table 44. Latin America, Middle East & Africa Tenofovir Disoproxil Fumarate Drug Substance Consumption by Country (2026-2031) & (Tons)
 Table 45. Global Tenofovir Disoproxil Fumarate Drug Substance Production (Tons) by Type (2020-2025)
 Table 46. Global Tenofovir Disoproxil Fumarate Drug Substance Production (Tons) by Type (2026-2031)
 Table 47. Global Tenofovir Disoproxil Fumarate Drug Substance Production Market Share by Type (2020-2025)
 Table 48. Global Tenofovir Disoproxil Fumarate Drug Substance Production Market Share by Type (2026-2031)
 Table 49. Global Tenofovir Disoproxil Fumarate Drug Substance Production Value (US$ Million) by Type (2020-2025)
 Table 50. Global Tenofovir Disoproxil Fumarate Drug Substance Production Value (US$ Million) by Type (2026-2031)
 Table 51. Global Tenofovir Disoproxil Fumarate Drug Substance Production Value Market Share by Type (2020-2025)
 Table 52. Global Tenofovir Disoproxil Fumarate Drug Substance Production Value Market Share by Type (2026-2031)
 Table 53. Global Tenofovir Disoproxil Fumarate Drug Substance Price (US$/Ton) by Type (2020-2025)
 Table 54. Global Tenofovir Disoproxil Fumarate Drug Substance Price (US$/Ton) by Type (2026-2031)
 Table 55. Global Tenofovir Disoproxil Fumarate Drug Substance Production (Tons) by Application (2020-2025)
 Table 56. Global Tenofovir Disoproxil Fumarate Drug Substance Production (Tons) by Application (2026-2031)
 Table 57. Global Tenofovir Disoproxil Fumarate Drug Substance Production Market Share by Application (2020-2025)
 Table 58. Global Tenofovir Disoproxil Fumarate Drug Substance Production Market Share by Application (2026-2031)
 Table 59. Global Tenofovir Disoproxil Fumarate Drug Substance Production Value (US$ Million) by Application (2020-2025)
 Table 60. Global Tenofovir Disoproxil Fumarate Drug Substance Production Value (US$ Million) by Application (2026-2031)
 Table 61. Global Tenofovir Disoproxil Fumarate Drug Substance Production Value Market Share by Application (2020-2025)
 Table 62. Global Tenofovir Disoproxil Fumarate Drug Substance Production Value Market Share by Application (2026-2031)
 Table 63. Global Tenofovir Disoproxil Fumarate Drug Substance Price (US$/Ton) by Application (2020-2025)
 Table 64. Global Tenofovir Disoproxil Fumarate Drug Substance Price (US$/Ton) by Application (2026-2031)
 Table 65. MACLEODS PHARMACEUTICALS LTD Tenofovir Disoproxil Fumarate Drug Substance Company Information
 Table 66. MACLEODS PHARMACEUTICALS LTD Tenofovir Disoproxil Fumarate Drug Substance Specification and Application
 Table 67. MACLEODS PHARMACEUTICALS LTD Tenofovir Disoproxil Fumarate Drug Substance Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 68. MACLEODS PHARMACEUTICALS LTD Main Business and Markets Served
 Table 69. MACLEODS PHARMACEUTICALS LTD Recent Developments/Updates
 Table 70. HETERO LABS LTD Tenofovir Disoproxil Fumarate Drug Substance Company Information
 Table 71. HETERO LABS LTD Tenofovir Disoproxil Fumarate Drug Substance Specification and Application
 Table 72. HETERO LABS LTD Tenofovir Disoproxil Fumarate Drug Substance Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 73. HETERO LABS LTD Main Business and Markets Served
 Table 74. HETERO LABS LTD Recent Developments/Updates
 Table 75. AUROBINDO PHARMA LTD Tenofovir Disoproxil Fumarate Drug Substance Company Information
 Table 76. AUROBINDO PHARMA LTD Tenofovir Disoproxil Fumarate Drug Substance Specification and Application
 Table 77. AUROBINDO PHARMA LTD Tenofovir Disoproxil Fumarate Drug Substance Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 78. AUROBINDO PHARMA LTD Main Business and Markets Served
 Table 79. AUROBINDO PHARMA LTD Recent Developments/Updates
 Table 80. MYLAN LABORATORIES LTD Tenofovir Disoproxil Fumarate Drug Substance Company Information
 Table 81. MYLAN LABORATORIES LTD Tenofovir Disoproxil Fumarate Drug Substance Specification and Application
 Table 82. MYLAN LABORATORIES LTD Tenofovir Disoproxil Fumarate Drug Substance Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 83. MYLAN LABORATORIES LTD Main Business and Markets Served
 Table 84. MYLAN LABORATORIES LTD Recent Developments/Updates
 Table 85. CIPLA LTD Tenofovir Disoproxil Fumarate Drug Substance Company Information
 Table 86. CIPLA LTD Tenofovir Disoproxil Fumarate Drug Substance Specification and Application
 Table 87. CIPLA LTD Tenofovir Disoproxil Fumarate Drug Substance Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 88. CIPLA LTD Main Business and Markets Served
 Table 89. CIPLA LTD Recent Developments/Updates
 Table 90. VIYASH LIFE SCIENCES PRIVATE LTD Tenofovir Disoproxil Fumarate Drug Substance Company Information
 Table 91. VIYASH LIFE SCIENCES PRIVATE LTD Tenofovir Disoproxil Fumarate Drug Substance Specification and Application
 Table 92. VIYASH LIFE SCIENCES PRIVATE LTD Tenofovir Disoproxil Fumarate Drug Substance Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 93. VIYASH LIFE SCIENCES PRIVATE LTD Main Business and Markets Served
 Table 94. VIYASH LIFE SCIENCES PRIVATE LTD Recent Developments/Updates
 Table 95. EMCURE PHARMACEUTICALS LTD Tenofovir Disoproxil Fumarate Drug Substance Company Information
 Table 96. EMCURE PHARMACEUTICALS LTD Tenofovir Disoproxil Fumarate Drug Substance Specification and Application
 Table 97. EMCURE PHARMACEUTICALS LTD Tenofovir Disoproxil Fumarate Drug Substance Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 98. EMCURE PHARMACEUTICALS LTD Main Business and Markets Served
 Table 99. EMCURE PHARMACEUTICALS LTD Recent Developments/Updates
 Table 100. STYRAX PHARMA PRIVATE LTD Tenofovir Disoproxil Fumarate Drug Substance Company Information
 Table 101. STYRAX PHARMA PRIVATE LTD Tenofovir Disoproxil Fumarate Drug Substance Specification and Application
 Table 102. STYRAX PHARMA PRIVATE LTD Tenofovir Disoproxil Fumarate Drug Substance Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 103. STYRAX PHARMA PRIVATE LTD Main Business and Markets Served
 Table 104. STYRAX PHARMA PRIVATE LTD Recent Developments/Updates
 Table 105. LAURUS LABS LTD Tenofovir Disoproxil Fumarate Drug Substance Company Information
 Table 106. LAURUS LABS LTD Tenofovir Disoproxil Fumarate Drug Substance Specification and Application
 Table 107. LAURUS LABS LTD Tenofovir Disoproxil Fumarate Drug Substance Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 108. LAURUS LABS LTD Main Business and Markets Served
 Table 109. LAURUS LABS LTD Recent Developments/Updates
 Table 110. AURISCO PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Company Information
 Table 111. AURISCO PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Specification and Application
 Table 112. AURISCO PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 113. AURISCO PHARMACEUTICAL CO LTD Main Business and Markets Served
 Table 114. AURISCO PHARMACEUTICAL CO LTD Recent Developments/Updates
 Table 115. ACEBRIGHT INDIA PHARMA PRIVATE LTD Tenofovir Disoproxil Fumarate Drug Substance Company Information
 Table 116. ACEBRIGHT INDIA PHARMA PRIVATE LTD Tenofovir Disoproxil Fumarate Drug Substance Specification and Application
 Table 117. ACEBRIGHT INDIA PHARMA PRIVATE LTD Tenofovir Disoproxil Fumarate Drug Substance Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 118. ACEBRIGHT INDIA PHARMA PRIVATE LTD Main Business and Markets Served
 Table 119. ACEBRIGHT INDIA PHARMA PRIVATE LTD Recent Developments/Updates
 Table 120. SOLARA ACTIVE PHARMA SCIENCES LTD Tenofovir Disoproxil Fumarate Drug Substance Company Information
 Table 121. SOLARA ACTIVE PHARMA SCIENCES LTD Tenofovir Disoproxil Fumarate Drug Substance Specification and Application
 Table 122. SOLARA ACTIVE PHARMA SCIENCES LTD Tenofovir Disoproxil Fumarate Drug Substance Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 123. SOLARA ACTIVE PHARMA SCIENCES LTD Main Business and Markets Served
 Table 124. SOLARA ACTIVE PHARMA SCIENCES LTD Recent Developments/Updates
 Table 125. LUPIN LTD Tenofovir Disoproxil Fumarate Drug Substance Company Information
 Table 126. LUPIN LTD Tenofovir Disoproxil Fumarate Drug Substance Specification and Application
 Table 127. LUPIN LTD Tenofovir Disoproxil Fumarate Drug Substance Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 128. LUPIN LTD Main Business and Markets Served
 Table 129. LUPIN LTD Recent Developments/Updates
 Table 130. SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Company Information
 Table 131. SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Specification and Application
 Table 132. SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 133. SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD Main Business and Markets Served
 Table 134. SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD Recent Developments/Updates
 Table 135. ZHEJIANG CANDORLY PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Company Information
 Table 136. ZHEJIANG CANDORLY PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Specification and Application
 Table 137. ZHEJIANG CANDORLY PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 138. ZHEJIANG CANDORLY PHARMACEUTICAL CO LTD Main Business and Markets Served
 Table 139. ZHEJIANG CANDORLY PHARMACEUTICAL CO LTD Recent Developments/Updates
 Table 140. ZHEJIANG SUPOR PHARMACEUTICALS CO LTD Tenofovir Disoproxil Fumarate Drug Substance Company Information
 Table 141. ZHEJIANG SUPOR PHARMACEUTICALS CO LTD Tenofovir Disoproxil Fumarate Drug Substance Specification and Application
 Table 142. ZHEJIANG SUPOR PHARMACEUTICALS CO LTD Tenofovir Disoproxil Fumarate Drug Substance Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 143. ZHEJIANG SUPOR PHARMACEUTICALS CO LTD Main Business and Markets Served
 Table 144. ZHEJIANG SUPOR PHARMACEUTICALS CO LTD Recent Developments/Updates
 Table 145. SHANDONG ANHONG PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Company Information
 Table 146. SHANDONG ANHONG PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Specification and Application
 Table 147. SHANDONG ANHONG PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 148. SHANDONG ANHONG PHARMACEUTICAL CO LTD Main Business and Markets Served
 Table 149. SHANDONG ANHONG PHARMACEUTICAL CO LTD Recent Developments/Updates
 Table 150. JINGMEN SHUAIBANG CHEMICAL SCIENCE AND TECHNOLOGY CO LTD Tenofovir Disoproxil Fumarate Drug Substance Company Information
 Table 151. JINGMEN SHUAIBANG CHEMICAL SCIENCE AND TECHNOLOGY CO LTD Tenofovir Disoproxil Fumarate Drug Substance Specification and Application
 Table 152. JINGMEN SHUAIBANG CHEMICAL SCIENCE AND TECHNOLOGY CO LTD Tenofovir Disoproxil Fumarate Drug Substance Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 153. JINGMEN SHUAIBANG CHEMICAL SCIENCE AND TECHNOLOGY CO LTD Main Business and Markets Served
 Table 154. JINGMEN SHUAIBANG CHEMICAL SCIENCE AND TECHNOLOGY CO LTD Recent Developments/Updates
 Table 155. ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Company Information
 Table 156. ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Specification and Application
 Table 157. ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD Tenofovir Disoproxil Fumarate Drug Substance Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 158. ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD Main Business and Markets Served
 Table 159. ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD Recent Developments/Updates
 Table 160. Key Raw Materials Lists
 Table 161. Raw Materials Key Suppliers Lists
 Table 162. Tenofovir Disoproxil Fumarate Drug Substance Distributors List
 Table 163. Tenofovir Disoproxil Fumarate Drug Substance Customers List
 Table 164. Tenofovir Disoproxil Fumarate Drug Substance Market Trends
 Table 165. Tenofovir Disoproxil Fumarate Drug Substance Market Drivers
 Table 166. Tenofovir Disoproxil Fumarate Drug Substance Market Challenges
 Table 167. Tenofovir Disoproxil Fumarate Drug Substance Market Restraints
 Table 168. Research Programs/Design for This Report
 Table 169. Key Data Information from Secondary Sources
 Table 170. Key Data Information from Primary Sources
 Table 171. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Tenofovir Disoproxil Fumarate Drug Substance
 Figure 2. Global Tenofovir Disoproxil Fumarate Drug Substance Market Value by Type, (US$ Million) & (2020-2031)
 Figure 3. Global Tenofovir Disoproxil Fumarate Drug Substance Market Share by Type: 2024 VS 2031
 Figure 4. Purity≥99% Product Picture
 Figure 5. Purity<99% Product Picture
 Figure 6. Global Tenofovir Disoproxil Fumarate Drug Substance Market Value by Application, (US$ Million) & (2020-2031)
 Figure 7. Global Tenofovir Disoproxil Fumarate Drug Substance Market Share by Application: 2024 VS 2031
 Figure 8. Tablet
 Figure 9. Granule
 Figure 10. Capsule
 Figure 11. Oral Powder
 Figure 12. Global Tenofovir Disoproxil Fumarate Drug Substance Production Value (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Tenofovir Disoproxil Fumarate Drug Substance Production Value (US$ Million) & (2020-2031)
 Figure 14. Global Tenofovir Disoproxil Fumarate Drug Substance Production Capacity (Tons) & (2020-2031)
 Figure 15. Global Tenofovir Disoproxil Fumarate Drug Substance Production (Tons) & (2020-2031)
 Figure 16. Global Tenofovir Disoproxil Fumarate Drug Substance Average Price (US$/Ton) & (2020-2031)
 Figure 17. Tenofovir Disoproxil Fumarate Drug Substance Report Years Considered
 Figure 18. Tenofovir Disoproxil Fumarate Drug Substance Production Share by Manufacturers in 2024
 Figure 19. Global Tenofovir Disoproxil Fumarate Drug Substance Production Value Share by Manufacturers (2024)
 Figure 20. Tenofovir Disoproxil Fumarate Drug Substance Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. The Global 5 and 10 Largest Players: Market Share by Tenofovir Disoproxil Fumarate Drug Substance Revenue in 2024
 Figure 22. Global Tenofovir Disoproxil Fumarate Drug Substance Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 23. Global Tenofovir Disoproxil Fumarate Drug Substance Production Value Market Share by Region: 2020 VS 2024 VS 2031
 Figure 24. Global Tenofovir Disoproxil Fumarate Drug Substance Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)
 Figure 25. Global Tenofovir Disoproxil Fumarate Drug Substance Production Market Share by Region: 2020 VS 2024 VS 2031
 Figure 26. North America Tenofovir Disoproxil Fumarate Drug Substance Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 27. Europe Tenofovir Disoproxil Fumarate Drug Substance Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 28. China Tenofovir Disoproxil Fumarate Drug Substance Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 29. Japan Tenofovir Disoproxil Fumarate Drug Substance Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 30. Global Tenofovir Disoproxil Fumarate Drug Substance Consumption by Region: 2020 VS 2024 VS 2031 (Tons)
 Figure 31. Global Tenofovir Disoproxil Fumarate Drug Substance Consumption Market Share by Region: 2020 VS 2024 VS 2031
 Figure 32. North America Tenofovir Disoproxil Fumarate Drug Substance Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 33. North America Tenofovir Disoproxil Fumarate Drug Substance Consumption Market Share by Country (2020-2031)
 Figure 34. U.S. Tenofovir Disoproxil Fumarate Drug Substance Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 35. Canada Tenofovir Disoproxil Fumarate Drug Substance Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 36. Europe Tenofovir Disoproxil Fumarate Drug Substance Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 37. Europe Tenofovir Disoproxil Fumarate Drug Substance Consumption Market Share by Country (2020-2031)
 Figure 38. Germany Tenofovir Disoproxil Fumarate Drug Substance Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 39. France Tenofovir Disoproxil Fumarate Drug Substance Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 40. U.K. Tenofovir Disoproxil Fumarate Drug Substance Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 41. Italy Tenofovir Disoproxil Fumarate Drug Substance Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 42. Russia Tenofovir Disoproxil Fumarate Drug Substance Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 43. Asia Pacific Tenofovir Disoproxil Fumarate Drug Substance Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 44. Asia Pacific Tenofovir Disoproxil Fumarate Drug Substance Consumption Market Share by Region (2020-2031)
 Figure 45. China Tenofovir Disoproxil Fumarate Drug Substance Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 46. Japan Tenofovir Disoproxil Fumarate Drug Substance Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 47. South Korea Tenofovir Disoproxil Fumarate Drug Substance Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 48. China Taiwan Tenofovir Disoproxil Fumarate Drug Substance Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 49. Southeast Asia Tenofovir Disoproxil Fumarate Drug Substance Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 50. India Tenofovir Disoproxil Fumarate Drug Substance Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 51. Latin America, Middle East & Africa Tenofovir Disoproxil Fumarate Drug Substance Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 52. Latin America, Middle East & Africa Tenofovir Disoproxil Fumarate Drug Substance Consumption Market Share by Country (2020-2031)
 Figure 53. Mexico Tenofovir Disoproxil Fumarate Drug Substance Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 54. Brazil Tenofovir Disoproxil Fumarate Drug Substance Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 55. Turkey Tenofovir Disoproxil Fumarate Drug Substance Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 56. GCC Countries Tenofovir Disoproxil Fumarate Drug Substance Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 57. Global Production Market Share of Tenofovir Disoproxil Fumarate Drug Substance by Type (2020-2031)
 Figure 58. Global Production Value Market Share of Tenofovir Disoproxil Fumarate Drug Substance by Type (2020-2031)
 Figure 59. Global Tenofovir Disoproxil Fumarate Drug Substance Price (US$/Ton) by Type (2020-2031)
 Figure 60. Global Production Market Share of Tenofovir Disoproxil Fumarate Drug Substance by Application (2020-2031)
 Figure 61. Global Production Value Market Share of Tenofovir Disoproxil Fumarate Drug Substance by Application (2020-2031)
 Figure 62. Global Tenofovir Disoproxil Fumarate Drug Substance Price (US$/Ton) by Application (2020-2031)
 Figure 63. Tenofovir Disoproxil Fumarate Drug Substance Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Global Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Research Report 2024
Global Tenofovir Disoproxil Fumarate Market Research Report 2024
Global Tenofovir Disoproxil Fumarate API Market Research Report 2025
Global Emtricitabine and Tenofovir Disoproxil Fumarate Tablets Market Research Report 2024
Global Tenofovir Emtricitabine Combination Drug Market Research Report 2024
Global Tenofovir Alafenamide Compound Drugs Market Research Report 2024
Global Tenofovir Alafenamide and Its Combination Drugs Market Research Report 2024
Anti HIV Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
HIV Medicines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Antiretroviral Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Tenoxicam API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pharmaceutical Grade Dimethyl Fumarate Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Efavirenz Tenofovir Emtricitabine Combination Drug Market Research Report 2024
Global HIV Antiretroviral Drug Market Research Report 2025
Global Anti Retroviral Drugs Market Research Report 2024
Antiviral Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Human Immunodeficiency Virus HIV Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Doxofylline API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global HIV Therapy Drug Market Research Report 2025
Global Efavirenz Lamivudine Tenofovir Compound Drugs Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions